Feasibility of a New Medtronic Experimental Automated Insulin Delivery (Artificial Pancreas) System

Not Applicable

• Conditions: type 1 diabetes; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12623001076662
• Lead Sponsor: St Vincent's Hospital Melbourne

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-10-09
• Last Update Posted: 16 October 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

Age > 18 years;
T1D of >1 year duration;
stable on Medtronic Minimed 780G system pump therapy for >3 months;
proficient in carbohydrate counting;
HbA1c <10.0%.

Exclusion Criteria

Pregnancy or planned pregnancy;
eGFR<40;
a history of diabetic ketoacidosis in the last 3 months;
diabetic gastroparesis;
tape allergy
major medical or psychiatric illness.

Study & Design

• Study Type: Interventional
• Study Design: Not specified